AAAAAA

   
Results: 1-13 |
Results: 13
Total synthesis of 12(R)-HETE, 12(S)-HETE, H-2(2)-12(R)-HETE and LTB4 fromracemic glycidol via hydrolytic kinetic resolution
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ Lee, TH
Citation: A. Rodriguez et al., Total synthesis of 12(R)-HETE, 12(S)-HETE, H-2(2)-12(R)-HETE and LTB4 fromracemic glycidol via hydrolytic kinetic resolution, TETRAHEDRON, 57(1), 2001, pp. 25-37
Total synthesis of leukotrienes from butadiene
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ Lee, TH
Citation: A. Rodriguez et al., Total synthesis of leukotrienes from butadiene, EUR J ORG C, (17), 2000, pp. 2991-3000
Structure-activity relationships on adrenoceptors and imidazoline-preferring binding sites (I-1,I-2-PBSs). Part 1: Weak intramolecular H-bond and conformational flexibility in a new I-1-PBS-selective imidazoline analogue, trans1-(4 ',5 '-dihydro-1 ' H-imidazol-2 '-yl)methyl-2-hydroxyindane (PMS 952)
Authors: Ye, HF Dive, G Dehareng, D Heymans, F Godfroid, JJ
Citation: Hf. Ye et al., Structure-activity relationships on adrenoceptors and imidazoline-preferring binding sites (I-1,I-2-PBSs). Part 1: Weak intramolecular H-bond and conformational flexibility in a new I-1-PBS-selective imidazoline analogue, trans1-(4 ',5 '-dihydro-1 ' H-imidazol-2 '-yl)methyl-2-hydroxyindane (PMS 952), BIO MED CH, 8(8), 2000, pp. 1861-1869
PMS-601: a new PAF-receptor antagonist with antiretroviral and anti-inflammatory properties.
Authors: Martin, M Serradji, N Dereuddre-Bosquet, N Bensaid, O Fichet, G Lamouri, A Heymans, F Clayette, P Godfroid, JJ Dormont, D
Citation: M. Martin et al., PMS-601: a new PAF-receptor antagonist with antiretroviral and anti-inflammatory properties., PATH BIOL, 48(5), 2000, pp. 513-519
PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages
Authors: Martin, M Serradji, N Dereuddre-Bosquet, N Le Pavec, G Fichet, G Lamouri, A Heymans, F Godfroid, JJ Clayette, P Dormont, D
Citation: M. Martin et al., PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages, ANTIM AG CH, 44(11), 2000, pp. 3150-3154
Total synthesis of lipoxin A(4) and lipoxin B-4 from butadiene
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ Lee, TH
Citation: A. Rodriguez et al., Total synthesis of lipoxin A(4) and lipoxin B-4 from butadiene, TETRAHEDR L, 41(6), 2000, pp. 823-826
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication
Authors: Serradji, N Bensaid, O Martin, M Kan, E Dereuddre-Bosquet, N Redeuilh, C Huet, J Heymans, F Lamouri, A Clayette, P Dong, CZ Dormont, D Godfroid, JJ
Citation: N. Serradji et al., Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication, J MED CHEM, 43(11), 2000, pp. 2149-2154
An efficient asymmetric synthesis of prostaglandin E-1
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ
Citation: A. Rodriguez et al., An efficient asymmetric synthesis of prostaglandin E-1, EUR J ORG C, (10), 1999, pp. 2655-2662
Synthesis of H-2(3)-labelled misoprostol and its primary plasma metabolite
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ
Citation: A. Rodriguez et al., Synthesis of H-2(3)-labelled misoprostol and its primary plasma metabolite, J LABEL C R, 42(9), 1999, pp. 843-850
Selective oxidation of primary silyl ethers and its application to the synthesis of natural products
Authors: Rodriguez, A Nomen, M Spur, BW Godfroid, JJ
Citation: A. Rodriguez et al., Selective oxidation of primary silyl ethers and its application to the synthesis of natural products, TETRAHEDR L, 40(28), 1999, pp. 5161-5164
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-,1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4 ',5 '-dihydro-1' H-imidazol-2 '-yl)piperazines and isosteric analogues of imidazoline
Authors: Le Bihan, G Rondu, F Pele-Tounian, A Wang, X Lidy, S Touboul, E Lamouri, A Dive, G Huet, J Pfeiffer, B Renard, P Guardiola-Lemaitre, B Manechez, D Penicaud, L Ktorza, A Godfroid, JJ
Citation: G. Le Bihan et al., Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-,1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4 ',5 '-dihydro-1' H-imidazol-2 '-yl)piperazines and isosteric analogues of imidazoline, J MED CHEM, 42(9), 1999, pp. 1587-1603
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats
Authors: Pele-Tounian, A Chan, SLF Rondu, F Le Bihan, G Giroix, MH Lamouri, A Touboul, E Pfeiffer, B Manechez, D Renard, P Guardiola-Lemaitre, B Godfroid, JJ Penicaud, L Morgan, NG Ktorza, A
Citation: A. Pele-tounian et al., Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats, EUR J PHARM, 377(1), 1999, pp. 81-87
In vitro mechanism of action on insulin release of S-22068, a new putativeantidiabetic compound
Authors: Le Brigand, L Virsolvy, A Manechez, D Godfroid, JJ Guardiola-Lemaitre, B Gribble, FM Ashcroft, FM Bataille, D
Citation: L. Le Brigand et al., In vitro mechanism of action on insulin release of S-22068, a new putativeantidiabetic compound, BR J PHARM, 128(5), 1999, pp. 1021-1026
Risultati: 1-13 |